Gamblin et al. 2003: Caspase cleavage of tauC3: Linking amyloid and neurofibrillary tangles in Alzheimer’s disease. Proc. Natl. Acad. Sci. U S A. 2003 Aug 19;100(17):10032-7.
Rissman et al., 2004. Caspase-cleavage of tauC3 is an early event in Alzheimer disease tangle pathology. J. Clin.Invest.. 2004 Jul;114(1):121-30.
De Calignon et al., 2010: Caspase activation precedes and leads to tangles.Nature. 22;464(7292):1201-4.
Quintanilla et al., 2011: TauC3 and Aβ cooperatively impair mitochondria in primary neurons.Neurobiol Aging. 33(3):61.
Zhao et al., 2015: Appoptosin-Mediated Caspase Cleavage of TauC3 Contributed to Progressive Supranuclear Palsy Pathogenesis. Neuron.87(5):963-75.
Ozcelik et al., 2016: Co-expression of truncated and full-length tau induces severe neurotoxicity.Mol. Psychiatry. 21(12): 1790–1798.
Kim et al., 2017: Caspase-cleaved TauC3 exhibits rapid memory impairment associated with tau oligomers in a transgenic mouse model. Neurobiol. Dis. 87:19-28..
Nicholls et al., 2017: Characterization of TauC3 antibody and demonstration of its potential to block tau propagation. PLoS One 22;12(5):e0177914.
Perez et al., 2017. Caspase-Cleaved Tau Impairs Mitochondrial Dynamics in Alzheimer’s Disease. Mol.Neurobiol. 2018 Feb;55(2):1004-1018.